Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : EPs 7630
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II/ Phase III
Recipient : Eskisehir Osmangazi University
Deal Size : Inapplicable
Deal Type : Inapplicable
Hand, Foot, and Mouth Disease: Could EPs®7630 be a Treatment Option
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
April 09, 2024
Lead Product(s) : EPs 7630
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II/ Phase III
Recipient : Eskisehir Osmangazi University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : AI201901
Therapeutic Area : Immunology
Study Phase : Phase III
Sponsor : Istanbul Umraniye Training and Research Hospital | Diskapi Yildirim Beyazit Education and Research Hospital | Antalya Training and Research Hospital | Dokuz Eylul University | Ankara City Hospital Bilkent | Kahramanmaras Sutcu Imam University | Uludag Uni
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy and Safety Study of AI201901 in Allergic Rhinitis Patients
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
January 28, 2021
Lead Product(s) : AI201901
Therapeutic Area : Immunology
Highest Development Status : Phase III
Sponsor : Istanbul Umraniye Training and Research Hospital | Diskapi Yildirim Beyazit Education and Research Hospital | Antalya Training and Research Hospital | Dokuz Eylul University | Ankara City Hospital Bilkent | Kahramanmaras Sutcu Imam University | Uludag Uni
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Naproxen Sodium
Therapeutic Area : Musculoskeletal
Study Phase : Phase IV
Recipient : Istanbul Medeniyet University
Deal Size : Inapplicable
Deal Type : Inapplicable
Evaluation of NaproxenSodium and CodeinePhosphate Combination in Osteoarthritis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 17, 2015
Lead Product(s) : Naproxen Sodium
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase IV
Recipient : Istanbul Medeniyet University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Dirithromycin
Therapeutic Area : Undisclosed
Study Phase : Phase I
Recipient : Pharmaceutical Research Unit, Jordan
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
September 11, 2014
Lead Product(s) : Dirithromycin
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Recipient : Pharmaceutical Research Unit, Jordan
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Dirithromycin
Therapeutic Area : Undisclosed
Study Phase : Phase I
Recipient : Pharmaceutical Research Unit, Jordan
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
September 11, 2014
Lead Product(s) : Dirithromycin
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Recipient : Pharmaceutical Research Unit, Jordan
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Dirithromycin
Therapeutic Area : Undisclosed
Study Phase : Phase I
Recipient : Pharmaceutical Research Unit, Jordan
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
July 10, 2014
Lead Product(s) : Dirithromycin
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Recipient : Pharmaceutical Research Unit, Jordan
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Dirithromycin
Therapeutic Area : Undisclosed
Study Phase : Phase I
Recipient : Pharmaceutical Research Unit, Jordan
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
July 10, 2014
Lead Product(s) : Dirithromycin
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Recipient : Pharmaceutical Research Unit, Jordan
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Udenafil
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy and Safety Study of Udenafil Tablets in Erectile Dysfunction.
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 28, 2011
Lead Product(s) : Udenafil
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
